Acumen Hypotension Prediction Index (HPI) Feature Software vs Strain AI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Acumen Hypotension Prediction Index (HPI) Feature Software

by Edwards Lifesciences

Strain AI

by Exo

AI Verdict

Tool A focuses on predicting hypotensive events using hemodynamic data for proactive management in acute care settings. Tool B, conversely, analyzes cardiac ultrasound images to measure Global Longitudinal Strain, assisting in the diagnosis of heart failure and cardiotoxicity. While both are cardiology AI tools, their distinct data inputs and clinical applications make them suitable for different diagnostic and monitoring needs.

Choose Acumen Hypotension Prediction Index (HPI) Feature Software if…

Choose Acumen Hypotension Prediction Index (HPI) Feature Software if your primary goal is proactive prevention and real-time management of hemodynamic instability and hypotension. This tool is ideal for critical care or surgical environments where early detection of impending hypotensive events, up to 15 minutes in advance, can significantly improve patient outcomes by allowing for timely interventions and optimized fluid and vasopressor management.

View Acumen Hypotension Prediction Index (HPI) Feature Software →

Choose Strain AI if…

Choose Strain AI if you need an efficient and accurate method for quantitatively assessing cardiac function through Global Longitudinal Strain (GLS) measurements from cardiac ultrasound images. This tool is best suited for cardiologists, oncologists, or radiologists who require AI-powered analysis to diagnose and monitor conditions such as heart failure or cardiotoxicity, streamlining diagnostic evaluation without extensive manual interpretation.

View Strain AI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Acumen Hypotension Prediction Index (HPI) Feature Software	Strain AI
Pricing	Unknown	Contact for pricing
Deployment	Unknown	On-device AI, operates without internet connection.
BAA Available	Unknown	Yes AI-estimated
FDA Status	Cleared AI-estimated	Yes AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Strain AI

Tool B's on-device AI and ability to operate without an internet connection suggest a highly robust and readily available solution at the point of care. This deployment model potentially simplifies implementation and reduces reliance on network infrastructure, offering a slight advantage in terms of immediate and reliable access for clinicians.

Clinical Value

Acumen Hypotension Prediction Index (HPI) Feature Software

Tool A explicitly states a 'demonstrated reduction in incidence, duration, and severity of intraoperative hypotension,' indicating a direct and measurable improvement in patient outcomes through proactive intervention. This predictive capability for a critical event offers a clear and immediate clinical advantage by enabling earlier intervention.

Pricing & Value

Tie

Both tools require direct contact with their respective vendors for pricing information, as this data is not publicly available. Without specific financial details for either product, it is impossible to conduct a head-to-head comparison of their pricing or overall value proposition.

Enterprise Readiness

Acumen Hypotension Prediction Index (HPI) Feature Software

Tool A's integration into the established Edwards Lifesciences HemoSphere advanced monitoring platform suggests a mature and well-supported ecosystem for enterprise deployment. While Tool B's on-device AI offers benefits, Tool A's deep integration with a widely used critical care platform likely streamlines implementation and ongoing support within large hospital systems.

Innovation

Acumen Hypotension Prediction Index (HPI) Feature Software

Tool A is described as a 'first-of-its-kind technology' that utilizes machine learning for predictive analysis of blood pressure waveforms to anticipate hypotensive events up to 15 minutes in advance. This proactive, predictive capability for a critical and common clinical challenge represents a significant innovation in patient monitoring and management.

Support & Docs

Tie

The provided information does not include specific details regarding the level of support or documentation available for either tool. Both Edwards Lifesciences and Exo are established companies in the medical technology sector, suggesting they would offer professional support, but without further data, a distinction cannot be made.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Acumen Hypotension Prediction Index (HPI) Feature Software	Strain AI
Product Name	Acumen Hypotension Prediction Index (HPI) Feature Software	Strain AI
Company	Edwards Lifesciences	Exo
Primary Function	Predictive monitoring tool using machine learning to detect and alert clinicians to the likelihood of a hypotensive event before it occurs, aiding in proactive hemodynamic management.	AI-powered medical software that analyzes cardiac ultrasound images to measure Global Longitudinal Strain (GLS), aiding physicians in assessing heart function and detecting conditions like heart failure and cardiotoxicity in adult patients.
Key Metric/Analysis	Hypotension Prediction Index (HPI) parameter (0-100 score), predictive analysis of blood pressure waveforms.	Measures Global Longitudinal Strain (GLS) from cardiac ultrasound images.
Input Data Type	Blood pressure waveforms (compatible with invasive arterial line and non-invasive Acumen IQ cuff monitoring).	Cardiac ultrasound images.
Target Conditions/Applications	Detection and prevention of hypotensive events, demonstrated reduction in incidence, duration, and severity of intraoperative hypotension.	Assessing heart function, detecting heart failure (CHF, HFpEF, HFrEF), hypertrophy, and cardiotoxicity in adult patients.
Specialties	Anesthesiology, Critical Care, Emergency Medicine	Cardiology, Oncology, Radiology

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index (HPI) Feature Software and Strain AI.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary clinical application and key output of each tool?

The Acumen HPI software is designed to predict and alert clinicians to the likelihood of a hypotensive event up to 15 minutes before it occurs, providing a Hypotension Prediction Index (HPI) parameter (0-100 score) for proactive hemodynamic management. Strain AI analyzes cardiac ultrasound images to measure Global Longitudinal Strain (GLS), aiding physicians in assessing heart function and detecting conditions such as heart failure and cardiotoxicity in adult patients.

What type of data input does each tool require for its analysis?

Acumen HPI utilizes machine learning algorithms to analyze blood pressure waveforms, compatible with both invasive (arterial line) and non-invasive (Acumen IQ cuff) monitoring. Strain AI analyzes cardiac ultrasound images to provide its insights.

How does each tool integrate into the clinical environment or existing equipment?

Acumen HPI is integrated into the Edwards Lifesciences HemoSphere advanced monitoring platform. Strain AI features on-device AI that operates without an internet connection and integrates with existing ultrasound devices.

In which medical specialties are these tools primarily intended for use?

Acumen HPI is designed for use in Anesthesiology, Critical Care, and Emergency Medicine. Strain AI is intended for use in Cardiology, Oncology, and Radiology.

Does either tool require an internet connection for its operation?

Strain AI operates with on-device AI and does not require an internet connection. The provided information for Acumen HPI does not explicitly state internet requirements, but it is integrated into a monitoring platform.

What specific patient outcomes or diagnostic benefits does each tool aim to provide?

Acumen HPI has demonstrated a reduction in the incidence, duration, and severity of intraoperative hypotension, aiding in improving patient outcomes through proactive management. Strain AI aids in assessing heart function, supports diagnostic evaluation without manual image interpretation, and assists in detecting heart failure (CHF, HFpEF, HFrEF) and hypertrophy.